PGR
65
-3
RHI
50
2
HOG
40
6
D
45
8
SNA
56
3
KMI
51
3
EQR
39
11
TAP
63
2
MOS
45
3
GME
49
2
XRX
55
13
ZION
63
8
VTR
52
5
SWK
64
9
PNR
57
6
ORCL
59
3
EL
37
3
NTRS
49
2
GPC
51
3
CNX
61
4
PGR
65
-3
RHI
50
2
HOG
40
6
D
45
8
SNA
56
3
KMI
51
3
EQR
39
11
TAP
63
2
MOS
45
3
GME
49
2
XRX
55
13
ZION
63
8
VTR
52
5
SWK
64
9
PNR
57
6
ORCL
59
3
EL
37
3
NTRS
49
2
GPC
51
3
CNX
61
4
Financhill
Back

NovoCure Stock Predictions

Tiny Lithium Stock Gets $90M Boost in Global EV Battery Race

Learn more here.
Sell
44

NVCR
NovoCure

Last Price:
13.21
Seasonality Move:
0.97%

7 Day Trial

ALL ACCESS PASS

$ 7

The Results Are In: Bryan Perry's "Million-Dollar Beta Test"

Click here to see how these extraordinary trading gains came to pass...and find out what Bryan has planned for the rest of 2023 - his fourth and final Beta Test.

NovoCure Stock Forecast

  • Over the next 52 weeks, NovoCure has on average historically risen by 27.4% based on the past 8 years of stock performance.
  • NovoCure has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is NovoCure Stock Undervalued?
    The current NovoCure [NVCR] share price is $12.50. The Score for NVCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will NovoCure Stock Go Up Next Year?

  • Over the next 52 weeks, NovoCure has on average historically risen by 27.4% based on the past 8 years of stock performance.

NovoCure Stock Rating

Sell
44
NovoCure (NVCR) is a Sell

Is NovoCure overpriced?

  • NovoCure has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

NovoCure Stock Price History

Is NVCR stock going to rise?

  • The current trend is relatively stagnant and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Info

Exchange:
NASDAQ
Country:
Jersey
Industry:
Medical Devices
Sector:
Healthcare
Type:
stock
Website:
novocure.com

52-Week Data

52-Week High:
120.03
52-Week Low:
10.87

Prediction Charts

Market Cap:
1.34B
Price in USD:
12.50
Volume:
1.26M
Beta:
0.92

Technical Analysis

SMA50:
13.80
SMA100:
21.16
SMA200:
41.97
52-Wk Change:
-84.67%

Stock Predictions

  • Is NovoCure stock public?
    Yes, NovoCure is a publicly traded company.
  • What is the NovoCure stock quote today?
    The NovoCure stock price is 12.50 USD today.
  • How to buy NovoCure stock online?
    You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-13 11.08 11.38 11.49 10.87
Nov-14 11.94 12.79 12.93 11.75
Nov-15 12.90 12.68 13.01 12.55
Nov-16 12.56 11.82 12.81 11.79
Nov-17 11.90 12.37 12.40 11.63
Nov-20 12.48 12.19 12.65 12.14
Nov-21 12.02 12.23 12.28 11.58
Nov-22 12.37 11.92 12.40 11.85
Nov-24 11.87 12.47 12.75 11.85
Nov-27 12.29 11.91 12.34 11.88
Nov-28 11.91 12.20 12.36 11.29
Nov-29 12.29 12.35 12.79 12.22
Nov-30 12.49 12.27 12.49 12.01
Dec-1 12.27 12.50 12.55 11.76

NovoCure Earnings

NovoCure Earnings Report: Per Share NovoCure Earnings Q1 Q2 Q3 and Q4 last year and next year.

NovoCure Forecast Revenue Growth

NovoCure Stock Analysis: Historical quarterly revenues per share for NovoCure and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.20 per share, and an increase next year of $0.07 per share.

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.